Oppenheimer & Co’s Kyverna Therapeutics KYTX Stock Holding History
Bought
Maintained
Sold
Other funds holding KYTX
ACM
Oppenheimer & Co's KYTX Position: Q3 2026 in Review
Oppenheimer & Co opened a new position in Kyverna Therapeutics (KYTX) in Q3 2026: 11,500 shares worth $78.2K. The stake represents ﹤0.01% of the portfolio and ranks #1718 among its holdings.
128 funds tracked by Wall St. Rank hold KYTX as of Q3 2026.
- Oppenheimer & Co held 11,500 shares of Kyverna Therapeutics worth $78.2K as of Q3 2026.
- Kyverna Therapeutics was a new Oppenheimer & Co position in Q3 2026.
- Kyverna Therapeutics made up ﹤0.01% of Oppenheimer & Co's portfolio in Q3 2026, its #1718 holding.
- 128 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q3 2026.
Based on Oppenheimer & Co's 13F filing for Q3 2026, filed 26 Oct 2026.